Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Schedule of Intangible Assets [Line Items] | ||
| Less: accumulated amortization | $ (289,971) | $ (92,415) |
| Total | 2,609,739 | 2,680,035 |
| 3D Global Patent [Member] | ||
| Schedule of Intangible Assets [Line Items] | ||
| Intangible assets, gross | 985,710 | 942,450 |
| EG BioMed Patent [Member] | ||
| Schedule of Intangible Assets [Line Items] | ||
| Intangible assets, gross | $ 1,914,000 | $ 1,830,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|